Skip to Content
Merck
  • SOD2 overexpression in bone marrow‑derived mesenchymal stem cells ameliorates hepatic ischemia/reperfusion injury.

SOD2 overexpression in bone marrow‑derived mesenchymal stem cells ameliorates hepatic ischemia/reperfusion injury.

Molecular medicine reports (2021-07-24)
Qiuyun Li, Wei Zhang, Enhua Xiao
ABSTRACT

Hepatic ischemia/reperfusion injury (HIRI) is a complex pathophysiological process that may develop after liver transplantation and resection surgery, as well as in uncontrolled clinical conditions. Bone marrow‑derived mesenchymal stem cells (BM‑MSCs) are potential targets for liver diseases. Thus, the present study aimed to investigate the effects of superoxide dismutase 2 (SOD2) overexpression in BM‑MSCs on HIRI by constructing a HIRI rat model. The adenoviral vector containing SOD2 and the corresponding control vector were designed and constructed, and SOD2‑overexpressing BM‑MSCs were injected into the tail vein of the rats. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, as well as pathological changes and the remnant liver regeneration rate were determined. The activities of SOD and glutathione peroxidase (GSH‑Px), and malondialdehyde (MDA) content were measured. Reactive oxygen species (ROS) were determined with 2',7'‑-dichlorofluorescein diacetate and measured via fluorescence microscopy. Cell apoptosis was assessed using TUNEL staining. Moreover, the expression levels of Bax, Bcl‑2 and caspase‑3 were detected via western blotting. SOD2‑overexpressing BM‑MSCs significantly reduced the elevation of serum AST and ALT levels. Furthermore, SOD2‑overexpressing BM‑MSCs enhanced SOD and GSH‑Px activities, and suppressed the production of MDA and ROS. Histopathological findings revealed that SOD2‑overexpressing BM‑MSCs decreased the number of TUNEL‑positive cells in the liver. It was also found that SOD2‑overexpressing BM‑MSCs promoted Bcl‑2 expression, but inhibited Bax and caspase‑3 expression in HIRI. Collectively, these findings suggest that SOD2‑overexpressing BM‑MSCs may provide therapeutic support in HIRI by inhibiting oxidative stress and hepatocyte apoptosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Human CD34 ELISA, for serum, plasma and cell culture supernatants
Sigma-Aldrich
Monoclonal Anti-CD90-APC antibody produced in mouse, clone 5E10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Fluorometric Intracellular Ros Kit, sufficient for 200 fluorometric tests (green)
Sigma-Aldrich
Glutathione Assay Kit, sufficient for 700 assays
Sigma-Aldrich
Anti-BCL-2 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-BAX antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
SOD Assay Kit, sufficient for 500 tests
Sigma-Aldrich
Anti-Caspase 3, Active antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-β-Actin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Rabbit Anti-Mouse IgG Antibody, HRP conjugate, Chemicon®, from rabbit
Sigma-Aldrich
Anti-Endoglin (CD105) Antibody, clone 44G4, clone 44G4, from mouse
Roche
In Situ Cell Death Detection Kit, Fluorescein, sufficient for ≤50 tests, suitable for detection